Chromatography Instruments Market – {By System [LC (HPLC, UHPLC, Flash), GC, Other Components
(Autosamplers, Detectors, Fraction Collectors)], By Consumable (Reverse Phase
Columns, Syringe Filters, Vials)} - Analysis & Global Forecasts to 2022.
Chromatography
is versatile analytical technique used to separate a mixture into its
individual components. Thus, chromatography is extensively used by pharmaceutical and
biotechnology companies in drug discovery and development, in environment and
food & beverage testing, and among others. Depending on the sample to be
analyzed, liquid chromatography (LC), gas chromatography (GC), supercritical
fluid chromatography (SFC), and thin-layer chromatography (TLC) techniques are predominantly
used.
View
more detailed TOC @ http://www.marketsandmarkets.com/Market-Reports/chromatography-instrumentation-market-1258.html
Growth in the chromatography instruments market is likely to
be centered in the Asia-Pacific region. Growth in Asia-Pacific can be attributed
to government investments in biomedical industry in China, strategic expansions
of chromatography players in China, increasing focus on soil testing in India,
food security concerns in India, and presence of bioclusters in India and
China.
The key industry players like Bruker Corporation (U.S.), Thermo
Fisher Scientific, Inc. (U.S.), and Shimadzu Corporation (Japan) are
establishing their presence in China by establishing new facilities, R&D
centers, and innovation centers in the country. Apart from this, the government
investment in the Chinese biomedical industry that comprises biological drugs,
medical equipment & materials, and bioagriculture has propelled the market
for chromatography instrumentation. In addition, the development of innovation
cluster named BioBay (China) that is focused on increasing R&D activities
among emerging biological and nanotechnology companies is bolstering the market
for chromatography instrumentation in China.
The free trade agreement between Korea and the
U.S. increased opportunities to import medical and research equipment into
Korea. The strong shipping and air cargo infrastructure in Korea further
accelerates the movement of goods and services. Furthermore, in January 2013,
the European Union (EU) announced that by July 2013, drugs, active
pharmaceutical ingredients (APIs), and excipients exported by New Zealand and
Australia should comply with the standards equivalent to the European Good
Manufacturing Practice (GMP). This step would ensure that the drugs exported by
these countries need not go through additional quality checks in Europe, thus
eliminating delays in their export. The increase in exports will increase the
demand for chromatography instruments required in the Quality Assurance (QA)
and Quality Control (QC) of these drugs.
No comments:
Post a Comment